Powered by

FibroGen admits to messing with roxadustat safety data, upending hopes for the AZ-partnered anemia drug

Apr 07, 2021 - FiercePharma

In a stunning revelation, FibroGen admitted to presenting roxadustat data manipulated to make the anemia drug look safer than it is. The late-Tuesday announcement sent FibroGen shares tumbling and prompted analysts to reassess the potential first-in-class therapy ahead of an FDA decision.

In a stunning revelation, FibroGen admitted to presenting roxadustat data manipulated to make the anemia drug look safer than it is.

The late-Tuesday announcement sent FibroGen shares tumbling and p...